JP7660898B2 - マイクロｒｎａを含む体液抽出物 - Google Patents

マイクロｒｎａを含む体液抽出物 Download PDF

Info

Publication number
JP7660898B2
JP7660898B2 JP2021545654A JP2021545654A JP7660898B2 JP 7660898 B2 JP7660898 B2 JP 7660898B2 JP 2021545654 A JP2021545654 A JP 2021545654A JP 2021545654 A JP2021545654 A JP 2021545654A JP 7660898 B2 JP7660898 B2 JP 7660898B2
Authority
JP
Japan
Prior art keywords
mir
hsa
microrna
tables
micrornas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021545654A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021049671A1 (https=
Inventor
隆雄 安井
嘉信 馬場
裕樹 市川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Craif Inc
Original Assignee
Craif Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Craif Inc filed Critical Craif Inc
Publication of JPWO2021049671A1 publication Critical patent/JPWO2021049671A1/ja
Priority to JP2025052355A priority Critical patent/JP2025098184A/ja
Application granted granted Critical
Publication of JP7660898B2 publication Critical patent/JP7660898B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021545654A 2019-09-09 2020-09-08 マイクロｒｎａを含む体液抽出物 Active JP7660898B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025052355A JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロｒｎａを含む体液抽出物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019193847 2019-09-09
JP2019193847 2019-09-09
PCT/JP2020/037487 WO2021049671A1 (ja) 2019-09-09 2020-09-08 マイクロｒｎａを含む体液抽出物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025052355A Division JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロｒｎａを含む体液抽出物

Publications (2)

Publication Number Publication Date
JPWO2021049671A1 JPWO2021049671A1 (https=) 2021-03-18
JP7660898B2 true JP7660898B2 (ja) 2025-04-14

Family

ID=74865791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021545654A Active JP7660898B2 (ja) 2019-09-09 2020-09-08 マイクロｒｎａを含む体液抽出物
JP2025052355A Pending JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロｒｎａを含む体液抽出物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025052355A Pending JP2025098184A (ja) 2019-09-09 2025-03-26 マイクロｒｎａを含む体液抽出物

Country Status (5)

Country Link
US (1) US20230265521A1 (https=)
EP (1) EP4029940A4 (https=)
JP (2) JP7660898B2 (https=)
CN (1) CN115038796A (https=)
WO (1) WO2021049671A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110799648B (zh) * 2017-06-29 2024-03-22 东丽株式会社 用于检测肺癌的试剂盒、装置和方法
CN113134010B (zh) * 2020-01-20 2023-09-01 上海市生物医药技术研究院 一种靶向雌激素受体α的微小RNA及其抗肿瘤用途
CN111534598B (zh) * 2020-06-11 2023-05-02 广西医科大学第一附属医院 与结直肠癌患者肿瘤突变负荷水平相关的miRNA标志物及应用
EP4211273B1 (en) * 2020-09-14 2025-10-29 Institut National de la Santé et de la Recherche Médicale Method to treat and stratificate a patient suffering from a cancer
EP4314321A4 (en) * 2021-03-24 2025-06-04 Craif Inc. MIARN, COMPOSITIONS AND METHODS OF USE THEREOF
CN113249488A (zh) * 2021-06-29 2021-08-13 中国人民解放军空军军医大学 基于外泌体miRNA-4433-5p表达水平的胃癌恶液质早期诊断试剂盒
CN115198014A (zh) * 2021-12-03 2022-10-18 武汉博越致和生物科技有限公司 一种用于胰腺癌早期诊断的外泌体miRNA标志物组合及检测试剂盒
CN114540491B (zh) * 2021-12-08 2024-01-30 北京尧景基因技术有限公司 一种基于岩藻糖基化细胞外囊泡中差异化表达miRNA的肝癌预测模型建立及应用
CN114672560B (zh) * 2022-01-12 2025-09-26 北京艾克伦医疗科技有限公司 通过外泌体miRNA标志物鉴定结直肠癌状态的检测试剂盒和方法
CN115141882A (zh) * 2022-02-23 2022-10-04 南方医科大学南方医院 黄韧带肥厚早期诊断用miRNA生物标志物、试剂盒及应用
JP2025506080A (ja) * 2022-03-09 2025-03-07 Ｃｒａｉｆ株式会社 疾患アウトカムを分類する方法
CN114686586B (zh) * 2022-05-05 2023-10-20 首都医科大学附属北京胸科医院 一种用于诊断结核性胸膜炎的分子标志物组合物及其应用
CN114686593B (zh) * 2022-05-30 2022-10-25 深圳市慢性病防治中心(深圳市皮肤病防治研究所、深圳市肺部疾病防治研究所) 与乳腺癌有关的外泌体SmallRNA及其应用
CA3254846A1 (en) * 2022-06-10 2023-12-14 City Of Hope Biomarkers in pancreatic cancer
CN114959014B (zh) * 2022-06-17 2023-03-31 中山大学附属第一医院 血清miRNAs作为绝经后骨质疏松联合诊断标志物的应用
US20250382673A1 (en) * 2022-07-01 2025-12-18 City Of Hope Biomarkers in colorectal cancer
CN117802232B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液小型胞外囊泡miRNA在卵巢癌诊断中的应用
CN117802235B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液胞外囊泡miRNA在卵巢癌诊断中的应用
CN116024330B (zh) * 2022-12-07 2023-12-01 中国医学科学院北京协和医院 miR-137-3p在薄型子宫内膜中的应用
CN116121382A (zh) * 2022-12-15 2023-05-16 康德（深圳）生物技术有限公司 一种用于胰腺癌精准用药生物标志物的筛选方法及其专用标志物
CN116144777A (zh) * 2022-12-30 2023-05-23 贵州医科大学 用于癌症筛查的基于m1A相关miRNA诊断试剂、模型及制备方法
CN115896295A (zh) * 2022-12-30 2023-04-04 中国科学技术大学 辅助诊断胆囊炎或预测胆囊炎合并肝损伤的miRNA标志物
CN116144781B (zh) * 2023-03-23 2024-08-13 刘忠祥 用于检测肺腺癌的标记物、引物组以及试剂盒
CN116492464B (zh) * 2023-04-12 2025-08-19 天津医科大学总医院 TNFRSF1A抑制剂miR-3059-5p在治疗脑卒中疾病中的用途
WO2024232682A1 (ko) * 2023-05-09 2024-11-14 솔바이오 주식회사 전립선암의 진단 및 치료 타겟으로서 mir-6880-5p
CN116898868B (zh) * 2023-05-19 2024-02-06 青岛大学附属医院 MiR-1909-5p在制备治疗血管内皮细胞铁死亡和/或主动脉夹层产品中的应用
CN117530932B (zh) * 2024-01-08 2024-04-26 中国药科大学 一种抑制肿瘤生长及肺转移的人工外泌体及其应用
CN118932040A (zh) * 2024-07-22 2024-11-12 南通大学附属医院 miR-3591-5p作为先天性心脏病合并肺动脉高压诊断标志的应用及检测试剂盒
CN119144728B (zh) * 2024-11-19 2025-04-29 四川大学华西医院 原发性肝癌的MicroRNA标志物的引物、试剂盒和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018504915A (ja) 2015-02-11 2018-02-22 エクシコン エ／エス 尿中の前立腺癌の早期発見のためのｍｉｃｒｏＲＮＡに基づく方法
JP2020092688A (ja) 2018-12-12 2020-06-18 国立大学法人東海国立大学機構 マイクロｒｎａを含む体液抽出物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103320504A (zh) * 2013-01-28 2013-09-25 深圳市人民医院 检测排泄物中microRNAs作为肺癌、结直肠癌和膀胱癌早期诊断生物标志
JP6606786B2 (ja) * 2014-03-12 2019-11-20 国立大学法人名古屋大学 生体分子抽出用チップ、及び生体分子抽出用チップの製造方法
WO2016186987A1 (en) * 2015-05-15 2016-11-24 Trustees Of Dartmouth College Biomarker micrornas and method for determining tumor burden
US11571695B2 (en) * 2018-07-06 2023-02-07 Craif Inc. Fluidic device and method for separating biomolecules
WO2020090860A1 (ja) * 2018-10-30 2020-05-07 国立大学法人名古屋大学 ｍｉＲＮＡの抽出方法、および、ｍｉＲＮＡの解析方法
JPWO2020158832A1 (https=) * 2019-01-30 2020-08-06

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018504915A (ja) 2015-02-11 2018-02-22 エクシコン エ／エス 尿中の前立腺癌の早期発見のためのｍｉｃｒｏＲＮＡに基づく方法
JP2020092688A (ja) 2018-12-12 2020-06-18 国立大学法人東海国立大学機構 マイクロｒｎａを含む体液抽出物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YASUI, T. et al.，Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires，Sci. Adv.，2017年，vol.3, no.12, e1701133

Also Published As

Publication number Publication date
JPWO2021049671A1 (https=) 2021-03-18
EP4029940A1 (en) 2022-07-20
EP4029940A4 (en) 2024-02-28
JP2025098184A (ja) 2025-07-01
CN115038796A (zh) 2022-09-09
US20230265521A1 (en) 2023-08-24
WO2021049671A1 (ja) 2021-03-18

Similar Documents

Publication Publication Date Title
JP7660898B2 (ja) マイクロｒｎａを含む体液抽出物
US12442044B2 (en) Extract from a body fluid comprising a micro RNA
Faruq et al. microRNA: diagnostic perspective
Schwarzenbach Clinical relevance of circulating, cell-free and exosomal microRNAs in plasma and serum of breast cancer patients
JP5755569B2 (ja) 肺癌を検出する方法
CN103620019B (zh) 基于miRNA的通用筛选试验(UST)
US20140243240A1 (en) microRNA EXPRESSION PROFILING OF THYROID CANCER
US20110160290A1 (en) Use of extracellular rna to measure disease
WO2013107459A2 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
CN102369294A (zh) 非小细胞肺癌标记物及其检测方法、试剂盒和生物芯片
CN103003442A (zh) 一种通过微小rna表达水平评估人同种异体移植物状况的方法
JP2011501966A (ja) 結腸直腸癌監視のためのプロセス
CN102776185A (zh) 由血浆microRNA组合成的肝癌诊断标志物及一种诊断肝癌的新方法
US20120108446A1 (en) 4-miRNA SIGNATURE FOR PREDICTING CLEAR CELL RENAL CELL CARCINOMA METASTASIS AND PROGNOSIS
CN104152452B (zh) 一种与肝癌相关的血液miRNA标志物及其应用
KR102096498B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로RNA-4732-5p 및 이의 용도
WO2011012074A1 (zh) 肝癌检测标记物及其检测方法、试剂盒和生物芯片
Bhadra et al. An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection
WO2011154008A1 (en) Microrna classification of thyroid follicular neoplasia
JP5798167B2 (ja) 組織傷害あるいは細胞増殖性疾患の検出方法
CN101555520A (zh) 早期预测慢性乙肝发展成肝硬化的hsa-mir-122试剂盒及检测方法
US20170298426A1 (en) Systems and methods for localized surface plasmon resonance biosensing
KR102096499B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3960 및 이의 용도
WO2014093504A1 (en) Microrna biomarkers for graft versus host disease
TW201418472A (zh) 由血漿ｍｉｃｒｏＲＮＡ組合成之肝癌診斷標誌物及診斷肝癌之新方法

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20230201

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250117

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250326

R150 Certificate of patent or registration of utility model

Ref document number: 7660898

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350